Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

dominoes stop stall halt end red
Biotech

Traws defers midphase flu study after negative regulatory review

Regulators issued a “negative review” of Traws' planned flu challenge study, forcing the biotech to defer a phase 2a tied to $20 million in funding.
Nick Paul Taylor Jun 15, 2026 9:19am
Wooden blocks with arrow and error icon Delays and disruptions stop the process critical error concept

Soligenix axes lymphoma program after phase 3 setback

Jun 15, 2026 7:53am
How NECs AI and oral delivery system are redefining personalized cancer therapy

How NEC's AI and oral delivery system are redefining personalized cancer therapy

Brought to you by NEC Bio
Lilly

Lilly’s $2.3B Ajax drug works ‘right out of the gate’

Jun 13, 2026 11:15am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Bull market

Biotech IPOs here to stay after another record-breaking listing

Jun 12, 2026 11:00am